OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | -50.0% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $10,000 | 0.0% | 1,500 | -50.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | 0.0% | 3,000 | -28.6% | 0.00% | 0.0% |
| Q1 2018 | $10,000 | -16.7% | 4,200 | -49.5% | 0.00% | – |
| Q4 2017 | $12,000 | -7.7% | 8,313 | -25.8% | 0.00% | – |
| Q3 2017 | $13,000 | -94.9% | 11,200 | -88.4% | 0.00% | -100.0% |
| Q2 2017 | $257,000 | -23.3% | 96,941 | +33.6% | 0.01% | -35.7% |
| Q1 2017 | $335,000 | +0.9% | 72,547 | +39.4% | 0.01% | +16.7% |
| Q4 2016 | $332,000 | +96.4% | 52,044 | +35.5% | 0.01% | +71.4% |
| Q3 2016 | $169,000 | +2314.3% | 38,403 | +1921.2% | 0.01% | – |
| Q2 2016 | $7,000 | 0.0% | 1,900 | +137.5% | 0.00% | – |
| Q1 2016 | $7,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |